Jim Saulnier & Associates, LLC Novo Nordisk A S Transaction History
Jim Saulnier & Associates, LLC
- $116 Billion
- Q4 2024
A detailed history of Jim Saulnier & Associates, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jim Saulnier & Associates, LLC holds 6,314 shares of NVO stock, worth $528,734. This represents 0.47% of its overall portfolio holdings.
Number of Shares
6,314
Previous 6,314
-0.0%
Holding current value
$528,734
Previous $752 Million
27.76%
% of portfolio
0.47%
Previous 0.74%
Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,879Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.67 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.3 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.09 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.06 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.02 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $189B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...